• 119
  • 46
  • Favorite

Dosing underway in BioNTech's Phase 2 trial of mrna-based BNT111 in advanced melanoma

seekingalpha2021-06-18

BioNTech(NASDAQ:BNTX)announcesthat the first patient has been treated in its Phase 2 cancer vaccine trial, evaluating the Company’s BNT111in combination with Libtayo (cemiplimab), being co-developed ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment46

  • ongyiren
    ·2021-06-20
    Ok
    Reply
    Report
  • Pierroye
    ·2021-06-18
    Great. Like and comment pls
    Reply
    Report
  • LWayne
    ·2021-06-18
    More pls
    Reply
    Report
  • LaiSB
    ·2021-06-18
    Soon will up
    Reply
    Report
  • Jack1999
    ·2021-06-18
    Pls comment and like
    Reply
    Report
    Fold Replies
    • Ljj96
      Me too
      2021-06-18
      Reply
      Report
  • Mm101
    ·2021-06-18
     Nice
    Reply
    Report
  • MaxTay
    ·2021-06-18
    Like for me
    Reply
    Report
  • jying96
    ·2021-06-18
    Good news!
    Reply
    Report
  • Carrotcake
    ·2021-06-18
    Ahha
    Reply
    Report
  • leelunsean92
    ·2021-06-18
    Hmmm
    Reply
    Report
  • OpenSesame88
    ·2021-06-18
    Yes!
    Reply
    Report
  • Kaylie
    ·2021-06-18
    Wow!
    Reply
    Report
  • KTX
    ·2021-06-18
    Like n comment
    Reply
    Report
    Fold Replies
  • KLS99
    ·2021-06-18
    Good
    Reply
    Report
  • PerDerDer
    ·2021-06-18
    Like and comment please 
    Reply
    Report
    Fold Replies
    • MoonMoon
      Ok
      2021-06-18
      Reply
      Report
  • Jacjacjacjac
    ·2021-06-18
    We all know that investing in biotech stocks isn't for the faint of heart. They tend to be pretty volatile, experiencing massive price surges and slumps. The reason for all these swings is simple – biotech stocks trade on catalysts.
    Reply
    Report
    Fold Replies
    • AetherC
      agree
      2021-06-18
      Reply
      Report
  • ASMH
    ·2021-06-18
    Wow
    Reply
    Report
  • StarGate
    ·2021-06-18
    Should I buy this or Lily?
    Reply
    Report
    Fold Replies
    • StarGate
      Yes, holding Lily for numbers of years and one of my favourite stocks.
      2021-06-26
      Reply
      Report
    • StarGate
      lily
      2021-06-18
      Reply
      Report
    • leelunsean92
      Lily
      2021-06-18
      Reply
      Report
  • ZNEX
    ·2021-06-18
    Wow
    Reply
    Report
  • ann62
    ·2021-06-18
    Nice
    Reply
    Report
 
 
 
 

Most Discussed

 
 
 
 
 

7x24

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email:uservice@ttm.financial